<?xml version="1.0" encoding="UTF-8"?>
<p id="P35">The antiviral activity of penciclovir is similar to that of acyclovir, with efficacy against HSV-1, HSV-2, and VZV, and, to a lesser extent, against EBV.
 <sup>
  <xref ref-type="bibr" rid="R72">72</xref>
 </sup> Penciclovir is monophosphorylated by TK and subsequently by cellular kinases into active penciclovir-triphosphate, which inhibits herpes DNA polymerase activity by serving as a competitive inhibitor of deoxyguanosine triphosphate.
 <sup>
  <xref ref-type="bibr" rid="R73">73</xref>
 </sup> Penciclovir is approved as topical therapy for recurrent herpes labialis, resulting in a faster healing rate and reduction in pain and viral shedding.
 <sup>
  <xref ref-type="bibr" rid="R74">74</xref>
 </sup>
</p>
